Residual Adrenal Function in Autoimmune Addison’s Disease—Effect of Dual Therapy With Rituximab and Depot Tetracosactide

CONTEXT: In autoimmune Addison’s disease (AAD), exogenous glucocorticoid (GC) therapy is an imperfect substitute for physiological GC secretion. Patients on long-term steroid replacement have increased morbidity, reduced life expectancy, and poorer quality of life. OBJECTIVE: The objective of this a...

Descripción completa

Detalles Bibliográficos
Autores principales: Napier, Catherine, Gan, Earn H, Mitchell, Anna L, Gilligan, Lorna C, Rees, D Aled, Moran, Carla, Chatterjee, Krishna, Vaidya, Bijay, James, R Andrew, Mamoojee, Yaasir, Ashwell, Simon, Arlt, Wiebke, Pearce, Simon H S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067544/
https://www.ncbi.nlm.nih.gov/pubmed/31863094
http://dx.doi.org/10.1210/clinem/dgz287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067544/
https://www.ncbi.nlm.nih.gov/pubmed/31863094
http://dx.doi.org/10.1210/clinem/dgz287

Ejemplares similares